Chromogranins from Cell Biology to Physiology and Biomedicine

(nextflipdebug5) #1

246


Sanchez-Margalet V, Goberna R (1994a) Pancreastatin activates pertussis toxin-sensitive guanylate
cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes. J Cell Biochem
55:173–181
Sanchez-Margalet V, Goberna R (1994b) Pancreastatin inhibits insulin-stimulated glycogen syn-
thesis but not glycolysis in rat hepatocytes. Regul Pept 51:215–220
Sanchez-Margalet V, Gonzalez-Yanes C (1998) Pancreastatin inhibits insulin action in rat adipo-
cytes. Am J Phys 275:E1055–E1060
Sanchez-Margalet V, Santos-Alvarez J  (1997) Solubilization and molecular characterization of
active pancreastatin receptors from rat liver membranes. Endocrinology 138:1712–1718
Sanchez-Margalet V, Lucas M, Goberna R (1992) Pancreastatin increases cytosolic Ca2+ in insulin
secreting RINm5F cells. Mol Cell Endocrinol 88:129–133
Sanchez-Margalet V, Lucas M, Goberna R (1994a) Pancreastatin activates protein kinase C by
stimulating the formation of 1,2-diacylglycerol in rat hepatocytes. Biochem J 303(Pt 1):51–54
Sanchez-Margalet V, Valle M, Goberna R (1994b) Receptors for pancreastatin in rat liver mem-
branes: molecular identification and characterization by covalent cross-linking. Mol Pharmacol
46:24–29
Sanchez-Margalet V, Valle M, Lobon JA, Maldonado A, Escobar-Jimenez F, Olivan J, Perez-Cano
R, Goberna R (1995) Increased plasma pancreastatin-like immunoreactivity levels in non-
obese patients with essential hypertension. J Hypertens 13:251–258
Sanchez-Margalet V, Lucas M, Goberna R (1996) Pancreastatin: further evidence for its consider-
ation as a regulatory peptide. J Mol Endocrinol 16:1–8
Sanchez-Margalet V, Gonzalez-Yanes C, Santos-Alvarez J, Najib S (2000) Characterization of
pancreastatin receptor and signaling in rat HTC hepatoma cells. Eur J Pharmacol 397:229–235
Sanchez-Margalet V, Gonzalez-Yanes C, Najib S (2001) Pancreastatin, a chromogranin A-derived
peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma
cells. J Hepatol 35:80–85
Sanchez-Margalet V, Santos-Alvarez J, Diaz-Troya S (2003) Purification of pancreastatin receptor
from rat liver membranes. Methods Mol Biol 228:187–194
Sanchez-Margalet V, Gonzalez-Yanes C, Najib S, Santos-Alvarez J  (2010) Metabolic effects
and mechanism of action of the chromogranin A-derived peptide pancreastatin. Regul Pept
161:8–14
Santos-Alvarez J, Sanchez-Margalet V (1998) Pancreastatin activates beta3 isoform of phos-
pholipase C via G(alpha)11 protein stimulation in rat liver membranes. Mol Cell Endocrinol
143:101–106
Santos-Alvarez J, Sanchez-Margalet V (1999) G protein G alpha q/11 and G alpha i1,2 are acti-
vated by pancreastatin receptors in rat liver: studies with GTP-gamma 35S and azido-GTP-
alpha-32P. J Cell Biochem 73:469–477
Santos-Alvarez J, Sanchez-Margalet V (2000) Affinity purification of pancreastatin receptor-
Gq/11 protein complex from rat liver membranes. Arch Biochem Biophys 378:151–156
Santos-Alvarez J, Gonzalez-Yanes C, Sanchez-Margalet V (1998) Pancreastatin receptor is cou-
pled to a guanosine triphosphate-binding protein of the G(q/11)alpha family in rat liver mem-
branes. Hepatology 27:608–614
Schmidt WE, Creutzfeldt W (1991) Pancreastatin–a novel regulatory peptide? Acta Oncol
30:441–449
Schmidt WE, Siegel EG, Kratzin H, Creutzfeldt W (1988) Isolation and primary structure of
tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad
Sci U S A 85:8231–8235
Sekiya K, Haji M, Fukahori M, Takayanagi R, Ohashi M, Kurose S-n, Oyama M, Tateishi K,
Funakosh A, Nawata H (1994) Pancreastatin-like immunoreactivity of cerebrospinal fluid in
patients with Alzheimer type dementia: evidence of aberrant processing of pancreastatin in
Alzheimer type dementia. Neurosci Lett 177:123–126


N.E. Evtikhova et al.
Free download pdf